Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Standard Dosed Alectinib Versus Therapeutic Drug Monitoring Guided Alectinib Dosing

NCT05525338 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT05525338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05525338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Standard Dosed Alectinib Versus Therapeutic Drug Monitoring Guided Alectinib Dosing
Lead sponsor
University Medical Center Groningen
Phase
Phase 4
Overall status
Recruiting
Start date
March 23, 2022
Completion date
December 31, 2026
Enrollment
196 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic lymphoma kinase gene mutation, anaplastic lymphoma kinase gene translocation, carcinoma, non-small-cell lung, drug monitoring, lung cancer